<qa>  What is the purpose of this study?The purpose of this study is to evaluate the safety and efficacy of autologous Platelet Rich Plasma PRP and Platelet Poor Plasma PPP eye drops four times a day in the treatment of ocular graft versus host disease O-GVHD. In addition to their current medication except autologous serum drops, patients will receive PRP and PPP drops. 